Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

436 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Brentuximab Vedotin in CD30-Expressing Germ Cell Tumors After Chemotherapy Failure.
Necchi A, Anichini A, Raggi D, Giannatempo P, Magazzù D, Nicolai N, Colecchia M, Paolini B, Coradeschi E, Tassi E, Grazia G, Mortarini R, Calareso G, De Fato R, Togliardi E, Crippa F, Salvioni R, Valagussa P, Gianni AM. Necchi A, et al. Clin Genitourin Cancer. 2016 Aug;14(4):261-264.e4. doi: 10.1016/j.clgc.2016.03.020. Epub 2016 Mar 24. Clin Genitourin Cancer. 2016. PMID: 27105722 No abstract available.
Does oxaliplatin and paclitaxel combination show an activity of some extent in pretreated patients with germ-cell tumors?: Reply to the article "A phase II multicenter study of oxaliplatin in combination with paclitaxel in poor prognosis patients who failed cisplatin-based chemotherapy for germ-cell tumors" by C. Theodore et al. (Ann Oncol 2008; doi: 10.1093/annonc/mdn122).
Necchi A, Nicolai N, Salvioni R. Necchi A, et al. Ann Oncol. 2008 Aug;19(8):1509. doi: 10.1093/annonc/mdn371. Epub 2008 May 25. Ann Oncol. 2008. PMID: 18504250 Free article. No abstract available.
Understanding the somatic-type malignant differentiation in male germ-cell cancer: a work in progress. Response to the article by Spiess et al., Malignant transformation of testicular teratoma: a chemoresistant phenotype. Urol Oncol 2008;26:595-9.
Necchi A, Nicolai N, Colecchia M, Salvioni R. Necchi A, et al. Urol Oncol. 2009 Mar-Apr;27(2):218; author reply 218-9. doi: 10.1016/j.urolonc.2008.12.009. Urol Oncol. 2009. PMID: 19285238 No abstract available.
Penile cancer.
Salvioni R, Necchi A, Piva L, Colecchia M, Nicolai N. Salvioni R, et al. Among authors: necchi a. Urol Oncol. 2009 Nov-Dec;27(6):677-85. doi: 10.1016/j.urolonc.2009.07.017. Urol Oncol. 2009. PMID: 19879479
Retroperitoneal lymph node dissection with no adjuvant chemotherapy in clinical stage I nonseminomatous germ cell tumours: long-term outcome and analysis of risk factors of recurrence.
Nicolai N, Miceli R, Necchi A, Biasoni D, Catanzaro M, Milani A, Piva L, Pizzocaro G, Stagni S, Torelli T, Salvioni R. Nicolai N, et al. Among authors: necchi a. Eur Urol. 2010 Dec;58(6):912-8. doi: 10.1016/j.eururo.2010.08.032. Epub 2010 Aug 27. Eur Urol. 2010. PMID: 20817343
[Testis tumors: what is new?].
Necchi A, Nicolai N, Salvioni R. Necchi A, et al. Urologia. 2008 Apr-Jun;75(1):63-6. Urologia. 2008. PMID: 21086353 Italian.
436 results